Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades OncoSec Medical to Neutral

BTIG Downgrades OncoSec Medical to Neutral

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

November 14, 2022

1 minute read

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

‘Aeroclean Technologies Has Received FDA 510(K) Clearance On 11/30/2022 For Its Purgo UV Air Purifier’ – FDA

December 5, 12:04 PM

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K223328

July 12, 12:01 PM

Over the past 3 months, 11 analysts have published their opinion on Emerson Electric (NYSE:EMR) stock. These analysts…

July 20, 7:21 AM

Piper Sandler analyst Alexander Goldfarb maintains Essex Property Trust (NYSE:ESS) with a Overweight and lowers the price target from $340 to $320.

October 3, 5:00 PM

Over the past 3 months, 5 analysts have published their opinion on Equitrans Midstream (NYSE:ETRN) stock. These analysts…